Global anti osteoporosis therapy and fracture healing market is estimated to grow at a CAGR of 3.0% during the forecast period. A study was conducted to calculate the number of patients with hip fractures who subsequently initiate treatment with anti-osteoporotic medicine. Copenhagen University Hospital, Herlev, conducted a study from June 2019 to May 2020. A total of 627 patients were admitted with a hip or near-hip fracture in the one-year study period. At the time of the hip fracture, 570 patients were 65 years of age or older and 74% were women. Men were slightly younger than women at the time of fracture. At follow-up, 26% of the patients had died. However, the study unveiled that men had a higher death rate than women. Additionally, various initiatives programs, and spending on R&D by regulatory bodies, strengthen the market growth. For instance, in June 2021, a new joint initiative by the International Osteoporosis Foundation and Asia Pacific Orthopaedic Association calls on orthopaedic surgeons to strengthen collaboration with physicians to improve secondary fracture prevention and patient outcomes. The new publication features key messages related to fracture management, post-fracture rehabilitation, fracture healing and national fracture registries. Asian countries are facing the most marked increase in fragility fractures globally, with the number of people at high fracture risk expected to double from 2010-2030.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-osteoporosis-therapy-and-fracture-healing-market

Moreover, according to the International osteoporosis foundation, in 2022, there are 6.2 million Australians over the age of 50 with osteoporosis or osteopenia. That is a 31% increase from 2012. as per the same source, Asian countries will face the most marked increase in fractures globally, with projections suggesting that by 2050, 50% of hip fractures will occur in Asia, the majority of which will happen in China. The number of individuals at high fracture risk in the region is expected to double from 2010- 2030.

Market Coverage

The market number available for – 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered- 

o             By Drug Type

o             By Route of Administration

o             By Application

Regions Covered-

o             North America

o             Europe

o             Asia-Pacific

o             Rest of the World

Competitive Landscape- including GlaxoSmithKline, Medtronic Plc, Merck & Co. Inc.,Pfizer,  and others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Anti Osteoporosis Therapy and Fracture Healing Market Report Segment

By Drug Type  

Calcitonin
Bisphosphonates

o             Alendronate (Fosamax)

o             Risedronate (Actonel)

o             Ibandronate (Boniva)

o             Zoledronic acid (Reclast)

Hormone Replacement Therapy
Anabolics
Others (denosumab, and raloxifene)

By Route of Administration

Oral
Injectable

By Distribution Channel 

Clinics
Hospital Pharmacies
Drug Stores
Retail Pharmacies
E-Commerce

A full report of Anti Osteoporosis Therapy and Fracture Healing Market available @ https://www.omrglobal.com/industry-reports/anti-osteoporosis-therapy-and-fracture-healing-market

Anti Osteoporosis Therapy and Fracture Healing Market Report Segment by Region

North America          

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific   

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Amgen Inc
Bioventus
Djo LLC
Eli Lilly and Co.
Hoffmann-La Roche Ltd
Orthofix US LLC
OssaTechnics
Osteo-Pharma BV
Stryker
Teva Pharmaceutical Industries Ltd.

Reasons to Buying From us –

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404

Company Name: Orion Market Research